We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb Calls for Changes to Manufacturing Practices to Accelerate Drug Development
Gottlieb Calls for Changes to Manufacturing Practices to Accelerate Drug Development
March 15, 2006
Inadequate manufacturing processes are a main reason for slowdowns in the drug pipeline, a senior FDA official says.